CHC Healthcare Group (4164) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for CHC Healthcare Group (4164:TWSE), powered by AI.

Current Price
$30.95
P/E Ratio
30.7
Market Cap
5.2B
Sector
Healthcare
What is the CHC Healthcare Group stock price forecast?

CHC Healthcare Group is currently trading at $30.95. View real-time AI analysis on Alpha Lenz.

What is CHC Healthcare Group insider trading activity?

View the latest insider trading data for CHC Healthcare Group on Alpha Lenz.

What is CHC Healthcare Group's P/E ratio?

CHC Healthcare Group's P/E ratio is 30.7.

CHC Healthcare Group

NT$30.95
TWSE4164
Ask about CHC Healthcare Group's future dividend policy...
Alpha Chat Insight

CHC Healthcare Group trades at a P/E of 30.7 (premium valuation) with modest ROE of 2.6%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.

Ask for details

Company Overview

CHC Healthcare Group operates as a healthcare sector entity specializing in the distribution and maintenance of advanced medical imaging equipment. Their primary function is to enhance medical facilities' capabilities by providing state-of-the-art imaging solutions, thereby improving diagnostic accuracy and patient care. CHC Healthcare Group is known for its comprehensive services that cover everything from equipment installation to comprehensive maintenance and after-sales support. This ensures that healthcare providers can rely on uninterrupted service delivery and focus on patient outcomes. The company plays a critical role in the healthcare sector, impacting hospitals, diagnostic centers, and clinics across various regions. By partnering with leading global manufacturers in medical imaging technology, CHC Healthcare Group brings the latest advancements in imaging tools to the forefront, thereby driving the adoption of cutting-edge medical practices in the healthcare industry. Its market presence is significant, as it bridges the gap between innovative medical technology and clinical application, contributing to the overall improvement of healthcare quality and operational efficiency.

SectorHealthcare
IndustryMedical Distribution
0

Company Statistics

(FY 2024)

Profile

Market CapNT$5.16B
RevenueNT$3.60B
Shares Out0.00
Employees0

Margins

Gross21.08%
EBITDA26.48%
Operating6.57%
Pre-Tax6.19%
Net5.07%

Valuation

P/E30.65
P/B0.82
EV/Sales1.43
EV/EBITDA10.10
P/FCF-15.56

Growth (CAGR)

Rev 3Yr13.86%
Rev 5Yr4.07%
Op Inc 3Yr-21.73%
Op Inc 5Yr-14.25%
Net Inc 3Yr-21.70%
Net Inc 5Yr-14.10%

Returns

ROA1.31%
ROE2.64%
ROIC2.31%

Financial Health

Cash & Cash EquivalentsNT$1.64B
Net DebtNT$5.90B
Debt/Equity113.03%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
CHC Healthcare Group (Healthcare) Stock Forecast & Analysis $30.95 | Alpha Lenz